Judi Abbott Curry’s annual New York Medical and Life Sciences Year in Review was republished by DRI. In the piece Judi, member of the firm’s Medical and Life Sciences Industry Team, reviews, analyzes and shares potential implications for future life science cases, based on several key judicial holdings in New York in 2022 pertaining to pharmaceuticals – changes being affected, failure to warn and design defect; medical devices – instructions for use, liberal construction and consumer fraud; and class actions. Read the full article beginning on page 24.